Rothschild Asset Management Inc. lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 24.4% during the first quarter, Holdings Channel reports. The firm owned 2,769 shares of the company’s stock after selling 892 shares during the period. Rothschild Asset Management Inc.’s holdings in Henry Schein were worth $471,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. JPMorgan Chase & Co. raised its position in shares of Henry Schein by 12.4% in the first quarter. JPMorgan Chase & Co. now owns 1,515,861 shares of the company’s stock worth $257,650,000 after buying an additional 167,213 shares during the period. Atlanta Capital Management Co. L L C raised its position in shares of Henry Schein by 12.8% in the fourth quarter. Atlanta Capital Management Co. L L C now owns 1,468,262 shares of the company’s stock worth $222,750,000 after buying an additional 167,050 shares during the period. Swedbank raised its position in shares of Henry Schein by 1.6% in the first quarter. Swedbank now owns 1,257,291 shares of the company’s stock worth $213,702,000 after buying an additional 19,885 shares during the period. Norges Bank acquired a new position in shares of Henry Schein during the fourth quarter worth about $139,100,000. Finally, Bank of New York Mellon Corp raised its position in shares of Henry Schein by 11.2% in the first quarter. Bank of New York Mellon Corp now owns 848,639 shares of the company’s stock worth $144,244,000 after buying an additional 85,137 shares during the period. Institutional investors and hedge funds own 91.11% of the company’s stock.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Shares of Henry Schein, Inc. (HSIC) traded down 0.51% during midday trading on Friday, hitting $182.73. The company had a trading volume of 588,950 shares. The stock’s 50-day moving average price is $180.32 and its 200-day moving average price is $167.54. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The company has a market cap of $14.50 billion, a price-to-earnings ratio of 27.77 and a beta of 1.10.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 EPS for the quarter, topping the Zacks’ consensus estimate of $1.65 by $0.11. The firm had revenue of $2.92 billion during the quarter, compared to the consensus estimate of $2.83 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. The firm’s revenue was up 7.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.41 EPS. On average, equities research analysts forecast that Henry Schein, Inc. will post $7.28 EPS for the current year.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/rothschild-asset-management-inc-reduces-stake-in-henry-schein-inc-hsic/1372526.html.

HSIC has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $206.00 target price on the stock in a research report on Friday. Deutsche Bank AG initiated coverage on shares of Henry Schein in a research report on Wednesday, March 15th. They set a “hold” rating and a $174.00 target price on the stock. Evercore ISI raised their target price on shares of Henry Schein from $160.00 to $178.00 and gave the stock a “hold” rating in a research report on Tuesday, February 21st. Leerink Swann set a $183.00 target price on shares of Henry Schein and gave the stock a “hold” rating in a research report on Wednesday, February 22nd. Finally, Piper Jaffray Companies initiated coverage on shares of Henry Schein in a research report on Monday, June 12th. They set a “neutral” rating and a $200.00 target price on the stock. Nine research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $184.08.

In related news, EVP Gerald A. Benjamin sold 12,578 shares of the company’s stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total transaction of $2,202,407.80. Following the completion of the transaction, the executive vice president now directly owns 44,061 shares in the company, valued at approximately $7,715,081.10. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, SVP Lorelei Mcglynn sold 9,300 shares of the company’s stock in a transaction on Thursday, March 23rd. The stock was sold at an average price of $171.76, for a total value of $1,597,368.00. Following the transaction, the senior vice president now owns 33,048 shares of the company’s stock, valued at $5,676,324.48. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 31,847 shares of company stock valued at $5,511,353. 1.27% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.